Reuters logo
BRIEF-EU Medicines Agency approves Bristol-Myers's myeloma treatment
2016年1月29日 / 中午12点15分 / 2 年前

BRIEF-EU Medicines Agency approves Bristol-Myers's myeloma treatment

Jan 29 (Reuters) - EU Medicines Agency

* EU Medicines Agency recommendations for January 2016

* Recommends approval of Bristol-Myers Squibb’s myeloma treatment elotuzumab under accelerated assessment

* Recommends approval of Actelion’s selexipag to treat pulmonary arterial hypertension

* CHMP has adopted a final scientific opinion following its review of experimental ebola treatments

* Final report includes information on nine experimental medicines intended for the treatment of people infected with the ebola virus Link to source: (bit.ly/1UuXKvc)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below